Thyroxin Treatment Protects Against White Matter Injury in The Immature Brain via Brain-Derived Neurotrophic Factor

被引:50
|
作者
Hung, Pi-Lien [1 ,2 ]
Huang, Chao-Ching [4 ,5 ]
Huang, Hsiu-Mei [3 ]
Tu, Dom-Gene [6 ]
Chang, Ying-Chao [1 ,2 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Kaohsiung, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[4] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan
[6] Chia Yi Christian Hosp, Dept Nucl Med, Chiayi, Taiwan
关键词
brain-derived neurotrophic factor; hypoxic ischemia; immature brain; thyroxin; white matter injury; THYROID-HORMONE; OLIGODENDROCYTE DEVELOPMENT; PRETERM INFANTS; MESSENGER-RNA; HYPOTHYROXINEMIA; PREMATURITY; EXPRESSION; DAMAGE; RATS;
D O I
10.1161/STROKEAHA.113.001552
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose Low level of thyroid hormone is a strong independent risk factor for white matter (WM) injury, a major cause of cerebral palsy, in preterm infants. Thyroxin upregulates brain-derived neurotrophic factor during development. We hypothesized that thyroxin protected against preoligodendrocyte apoptosis and WM injury in the immature brain via upregulation of brain-derived neurotrophic factor. Methods Postpartum (P) day-7 male rat pups were exposed to hypoxic ischemia (HI) and intraperitoneally injected with thyroxin (T4; 0.2 mg/kg or 1 mg/kg) or normal saline immediately after HI at P9 and P11. WM damage was analyzed for myelin formation, axonal injury, astrogliosis, and preoligodendrocyte apoptosis. Neurotrophic factor expression was assessed by real-time polymerase chain reaction and immunohistochemistry. Neuromotor functions were measured using open-field locomotion (P11 and P21), inclined plane climbing (P11), and beam walking (P21). Intracerebroventricular injection of TrkB-Fc or systemic administration of 7,8-dihydroxyflavone was performed. Results On P11, the HI group had significantly lower blood T4 levels than the controls. The HI group showed ventriculomegaly and marked reduction of myelin basic protein immunoreactivities in the WM. T4 (1 mg/kg) treatment after HI markedly attenuated axonal injury, astrocytosis, and microgliosis, and increased preoligodendrocyte survival. In addition, T4 treatment significantly increased myelination and selectively upregulated brain-derived neurotrophic factor expression in the WM, and improved neuromotor deficits after HI. The protective effect of T4 on WM myelination and neuromotor performance after HI was significantly attenuated by TrkB-Fc. Systemic 7,8-dihydroxyflavone treatment ameliorated hypomyelination after HI injury. Conclusions T4 protects against WM injury at both pathological and functional levels via upregulation of brain-derived neurotrophic factor-TrkB signaling in the immature brain.
引用
收藏
页码:2275 / 2283
页数:9
相关论文
共 50 条
  • [41] Brain-Derived Neurotrophic Factor in Chronic Periodontitis
    Correa, Joice Dias
    Pereira, Daniele Sirineu
    Moreira Madeira, Mila Fernandes
    Queiroz-Junior, Celso Martins
    Souza, Danielle Gloria
    Teixeira, Mauro Martins
    Costa, Jose Eustaquio
    Teixeira, Antonio Lucio
    da Silva, Tarcilia Aparecida
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [42] Astrocytes and brain-derived neurotrophic factor (BDNF)
    Albini, Martina
    Krawczun-Rygmaczewska, Alicja
    Cesca, Fabrizia
    NEUROSCIENCE RESEARCH, 2023, 197 : 42 - 51
  • [43] The Effect of Brain-derived Neurotrophic Factor on Angiogenesis
    孙春艳
    胡豫
    褚章波
    黄靖
    张璐
    Current Medical Science, 2009, (02) : 139 - 143
  • [44] Brain-derived neurotrophic factor and antidepressant activity
    Russo-Neustadt, AA
    Chen, MJ
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (12) : 1495 - 1510
  • [45] Brain-Derived Neurotrophic Factor in Neonatal Seizures
    Sullivan, Brennan J.
    Kadam, Shilpa D.
    PEDIATRIC NEUROLOGY, 2021, 118 : 35 - 39
  • [46] Brain-derived neurotrophic factor in neurodegenerative diseases
    Chiara Zuccato
    Elena Cattaneo
    Nature Reviews Neurology, 2009, 5 : 311 - 322
  • [47] Brain-derived neurotrophic factor in primary headaches
    Marlene Fischer
    Georg Wille
    Stephanie Klien
    Hind Shanib
    Dagny Holle
    Charly Gaul
    Gregor Broessner
    The Journal of Headache and Pain, 2012, 13 : 469 - 475
  • [48] Brain-derived neurotrophic factor in neurodegenerative diseases
    Zuccato, Chiara
    Cattaneo, Elena
    NATURE REVIEWS NEUROLOGY, 2009, 5 (06) : 311 - 322
  • [49] The effect of brain-derived neurotrophic factor on angiogenesis
    Sun, Chunyan
    Hu, Yu
    Chu, Zhangbo
    Huang, Jing
    Zhang, Lu
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (02) : 139 - 143
  • [50] Brain-derived neurotrophic factor as a biomarker of insomnia
    Mikoteit, T.
    Brand, S.
    Eckert, A.
    Holsboer-Trachsler, E.
    Beck, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S514 - S515